Dry eye
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed dry eye and prescribed an eye drop in the treatment (Diquafosol sodium ophthalmic solution, Sodium hyaluronate ophthalmic solution 0.1%, or Rhebamipide opthhalmic suspension) Patients used the eye drop for more than 1 month.
Exclusion criteria
Exclusion criteria: Medical professionals (doctors, pharmacists, nurses, etc.) Patients engaged in pharmaceuticals and medical devices industry Patients engaged in pharmaceuticals distributor Patients engaged in information provision services, research services, and advertising Patients with diabetes mellitus or ocular infection Patients used eye drops in the treatment for glaucoma or seasonal allergic conjunctivitis Patients had a past history of ophthalmic surgery within 1 month Patients used a punctal plug and performed a punctal closure procedure Patients visited an eye clinic for the treatment of dry eye more over 3 months Patients used eye drops in the treatment for dry eye in combination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Use of eye drops in treatment for dry eye, and the reason how patients used The effects of subjective symptoms, quality of life and patient satisfaction by the use | — |
Countries
Japan
Contacts
Dry eye society Ophthalmology